These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 2842044)
1. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Gespach C; Bawab W; de Cremoux P; Calvo F Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044 [TBL] [Abstract][Full Text] [Related]
2. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas. Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium. Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439 [TBL] [Abstract][Full Text] [Related]
4. Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man. Gespach C; Bawab W; Chastre E; Emami S; Yanaihara N; Rosselin G Biochem Biophys Res Commun; 1988 Mar; 151(2):939-47. PubMed ID: 2831906 [TBL] [Abstract][Full Text] [Related]
5. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking. McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170 [TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68. Van Valen F; Jürgens H; Winkelmann W; Keck E Cell Signal; 1989; 1(5):435-46. PubMed ID: 2561912 [TBL] [Abstract][Full Text] [Related]
7. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes. Provow S; Veliçelebi G Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591 [TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex. Couvineau A; Gammeltoft S; Laburthe M J Neurochem; 1986 Nov; 47(5):1469-75. PubMed ID: 3020175 [TBL] [Abstract][Full Text] [Related]
9. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29. Couvineau A; Rousset M; Laburthe M Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337 [TBL] [Abstract][Full Text] [Related]
10. The human vasoactive intestinal peptide receptor: molecular identification by covalent cross-linking in colonic epithelium. Couvineau A; Laburthe M J Clin Endocrinol Metab; 1985 Jul; 61(1):50-5. PubMed ID: 2987295 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin. Andersson M; Carlquist M; Maletti M; Marie JC FEBS Lett; 1993 Feb; 318(1):35-40. PubMed ID: 8382169 [TBL] [Abstract][Full Text] [Related]
12. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB; Niewiadomski P; Nowak JZ Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130 [TBL] [Abstract][Full Text] [Related]
13. VIP receptors from porcine liver: high yield solubilization in a GTP-insensitive form. Voisin T; Couvineau A; Guijarro L; Laburthe M Life Sci; 1991; 48(2):135-41. PubMed ID: 1847224 [TBL] [Abstract][Full Text] [Related]
14. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism. Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304 [TBL] [Abstract][Full Text] [Related]
15. Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase. Besson J; Malassiné A; Ferré F Regul Pept; 1987 Nov; 19(3-4):197-207. PubMed ID: 2829291 [TBL] [Abstract][Full Text] [Related]
16. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle. Guijarro LG; Rodriguez-Pena MS; Prieto JC Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588 [TBL] [Abstract][Full Text] [Related]
17. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells. el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575 [TBL] [Abstract][Full Text] [Related]
18. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages. Sakakibara H; Shima K; Said SI Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252 [TBL] [Abstract][Full Text] [Related]
19. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts. Robberecht P; Waelbroeck M; De Neef P; Tastenoy M; Gourlet P; Cogniaux J; Christophe J FEBS Lett; 1988 Feb; 228(2):351-5. PubMed ID: 2830146 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides. Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]